Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: Relation to ventricular and myocyte function

Circulation Research

Volumn 82, Issue 4, 1998, Pages 482-495

  Spinale, Francis G ^a   Coker, Mytsi L ^a   Thomas, Chadwick V ^a   Walker, Jennifer D ^a   Mukherjee, Rupak ^a   Hebbar, Latha ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Heart failure; Metalloproteinase; Myocardial remodeling

Indexed keywords

COLLAGEN; COLLAGENASE; GELATINASE; MATRIX METALLOPROTEINASE; STROMELYSIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE COURSE; HEART DILATATION; HEART VENTRICLE REMODELING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SWINE;

EID: 0032498853     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.82.4.482     Document Type: Article

References (67)

1. Cohn JN, Francis GS. Cardiac failure: a revised paradigm. J Card Fail. 1995; 1:261-266.
2. Poole-Wilson PA. Relation of pathophysiologioal mechanisms to outcome in heart failure. J Am Coll Cardiol. 1993;22:4:22A-29A.
3. Cohn JN, Johnson GR, Shabetai R, Loeh H, Tristani F, Rector T, Smith R. Fletcher R, for the V-HeFT VA Cooperative Studies Group. Ejection fraction, peak exercise, oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. Circulation 1993;87(suppl VI);VI-5-VI-16.
4. Komamura K, Shannon RP, Paslpoulandcs A, Ihara T, Lader AS, Patrick TA, Bishop SP, Vatner SF. Alterations in left ventricular diastolic function in conscious dogs with pacing induced heart failure. J Clin Invest. 1992; 89:1825-1838.
5. Spinale FG, Zellner JL, Tomita M, Crawford FA, Zile MR. Relationship between ventricular and myocyte remodeling with the development and regression of supraventricular tachycardia-induced cardiomyopathy. Circ Res. 1991;69:1058-1067.
6. Spinale FG, Eulbright BM, Mukherje R, Tanaka R, Hu J, Crawford FA, Zile MR. Relationship between ventricular and myocyte function with tachycardia induced cardiomyopathy. Circ Res. 1992;71:174-187.
7. Zellner JL, Spinale FG, Eble DK, Hewett KW, Crawford FA Jr. Alterations in myocyte shape and basement membrane attachment with tachycardia-induced heart failure. Circ Res. 1991;69:590-600.
8. Tomita M, Spinale FG, Crawford FA, Zile MR. Changes in left ventricular volume, mass and function during development and regression of supraventricular tachycardia induced cardiomyopathy: disparity between recovery of systolic vs diastolic function. Circulation. 1991;83:635-644.
9. Spinale FG. Holzgrefe HH, Mukherjee R, Hird RB, Walker JD, Amim A.E, Powell JR, Koster WH. Angiotensin converting enzyme inhibition and the progression of congestive cardiomyopathy: effects on left ventricular and myocyte structure and function. Circulation. 1995;92:562-568.
10. Armstrong PW, Stopps TP, Ford SE, DeBold AJ. Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure. Circulation. 1986;74: 1075-1084.
11. Wang J, Seyedi N, Xu XB, Wolin MS, Hintze TH. Defective endothelium-medtated control of coronary circulation m conscious dogs after heart failure. Am J Physiol. 1994;266(pt 2):H670-H680.
12. Spinale FG, Tomita M, Zellner JL, Cook JC, Crawford FA, Zile MR. Collagen remodeling and changes in LV function during development and recovery from supraventrictilar tachycardia. Am J Physiol. 1991;261: H308-H318.
13. Komamura K, Shannon RP, Ihara T, Shen YT, Mirsky I, Bishop SP, Vatner SF. Exhaustion of the Frank-Starling mechanism in conscious dogs with heart failure. Am J Physiol. 1993;265:H1119-H1131.
14. Weber KT, Pick R, Stiver MA, Moe GW, Janicki JS, Zucker IH, Armstrong PW, Fibrillar collagen and remodeling of dilated canine left ventricle. Circulation. 1990;82:1387-1401.
15. Spinale FG. The extracellular matrix with the development and regression from dilated cardiomyopathy. In: Weber KT, ed. Wound Healing Responses in Cardiovascular Diseases. New York, NY: Futurs Press; 1995:83-98.
16. Benedict CR, Weincr DH, Johnstone DE, Bourassa MG, Ghali JK, Nicklas J, Kirlin P, Greenberg B, Quinones MA, Yusuf S. The SOLVD investigators. Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: results of the Studies of Left Ventricular Dysfunction (SOLVD) Registry. J Am Coll Cardiol. 1993;22:146A-153A.
17. 1-receptot down-regulation tn heart failure. Circ Res. 1986;59:297-309.
18. Factor SM. Role of extracellular matrix in dilated cardiomyopathy. Heart Failure. 1994;9:260-268.
19. Weber KT, Anversa P, Armstrong PW, Brilla CG, Burnett JC, Cruickshank JM, Devereux RB, Giles TO, Corsgaard N, Leier CV, Mendelsohn FAO, Motz WH, Mulvany MI, Strauer BE. Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol. 1992;20:3-16.
20. Borg TR, Burgess ML, Holding it all together: organization and function(s) of the extracellular matrix of the heart. Heart Failure. 1993;8:230-238.
21. Janicki JS, Matsubara BB. Myocardial collagen and left ventricular diastolic dysfunction. In: Gaash WH, LeWinter MM, eds. Left Ventricular Diastalic Dysfunction and Heart Failure. Philadelphia, Pa: Lea & Febiger; 1994: 125-140.
22. Bishop SP, Powell PC, Brissie N, Komamura K, Shannon RP, Myocardial cellular remodeling in canine pacing induced heart failure. Circulation. 1992;86(suppl I):I-754. Abstract.
23. Woessner FJ. Matrix metalloproteinases and their inhibitors in connective tissue remodeling, FASEB J. 1991;5:2145-2154.
24. Stetler-Stevenson WG. Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am J Pathol. 1996;148:1345-1350.
25. Matrisian LM, Hogan BLM. Growth factor regulated proteases and extracellular matrix remodeling during mammalian development, Curr Top Dev Biol. 1990;24:219-259.
26. Lee E, Vaughan DE, Parikh SH, Grodzinsky AJ, Libby P, Lark MW, Lee RT. Regulation of matrix metalloproteinases and plasminogen activator inhibitor-1 synthesis by plasminogen in cultured human vascular smooth muscle cells. Circ Res. 1996;78:44-49.
27. Nagase H, Enghild JJ, Suzuki K, Salvesen G. Stepwise activation mechanisms of the precursor of the matrix metalloproteinase 3 (stromelysin) by proteinases and mercuric acetate. Biochemistry. 1990;29:5783-5789.
28. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemori EN, Lark MW, Amento E, Libby P. Cytokine stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res. 1994;75:181-189.
29. Werb Z, Alexander CM. Proteinases and matrix degradation. In: Kelly WN, Harris ED, Ruddy S, Sledge CD, eds. Textbook of Rheumatology. New York, NY: WB Saunders; 1993:248-268.
30. Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinases and cardiovascular disease. Circ Res. 1995;77:863-868.
31. Galis ZS, Sukhova GK, Larck MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94: 2493-2503.
32. Janicki JS, Henegar JR, Campbell SE, Tyagi SC. Myocardial collagenase activity in experimental dilated cardiomyopathy. In: Weber KT, ed. Wound Healing Responses in Cardiovascular Diseases. New York, NY: Futura Press; 1995:73-81.
33. Armstrong PW, Moe GW, Howard RJ, Grima E, Cruz TF. Structural remodeling in heart failure: gelatinase induction. Can J Cardiol. 1994;10: 214-220.
34. Gunja-Smith A, Morales AR, Romanelli R, Woessner JF. Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy. Am J Pathol. 1996;148:1639-1648.
35. Zile MR, Tanaka R, Lindroth JR, Spinale FG, Carabello BA, Mirsky I. Left ventricular volume determined echocardiographically by using a constant LV epicardial long axis to short axis dimension ratio throughout the cardiac cycle. J Am Coll Cardiol. 1992;20:986-993.
36. Colan SD, Borrow KM, Neuman A. Left ventricular end-systolic wall stress-velocity of fiber shortening relation: a load independent index of myocardial contractility. J Am Coll Cardiol. 1984;4:715-724.
37. Gaasch WH, Freeman GL. Functional properties of normal and failing hearts. In: McCall D, Rahimtoola SH, eds. Heart Failure. New York, NY: Chapman and Hall; 1995:14-29.
38. Morgan DE, Tomlinson CW, Qayumi AK, Toleikis PM, McConville B, Jamieson WRE. Evaluation of ventricular contractility indexes in the dog with left ventricular dysfunction induced by rapid atrial pacing. J Am Coll Cardiol. 1989;14:489-495.
39. Gunther S, Grossman W. Determinants of ventricular function in pressure-overload hypertrophy in man. Circulation. 1979;59:679-688.
40. Ross J Jr. Afterload mismatch and preload reserve: a conceptual framework for the analysis of ventricular function. Prog Cardiovasc Dis. 1976;18: 255-264.
41. Nigatsu M, Zile MR, Tsutsui H, Schmidt PG, DeFreyte G, Cooper G, Carabello BA. Native β-adrenergic support for left ventricular dysfunction in experimental mitral regurgitation normalizes indexes of pump and contractile function. Circulation. 1994;89:818-826.
42. Nakano K, Sugawara M, Ishihara K, Kanazawa S, Corin WJ, Denslow SD, Biederman RWW, Carabello BA. Myocardial stiffness derived from endsystolic wall stress and logarithm of reciprocal of wall thickness: contractility index independent of ventricular size. Circulation. 1990;82:1352-1361.
43. Whittaker P, Kloner RA, Boughner DR, Pickering JG. Quantitative assessment of myocardial collagen with picosirius red staining and circularly polarized light. Basic Res Cardiol. 1994;89:397-410.
44. Weibel ER. Practical methods for biological morphometry. In: Stereological Methods. London, UK: Academic Press; 1979;1:101-161.
45. Morodomi T, Ogata Y, Sasaguri Y, Morimatsu M, Nagase H. Purification and characterization of matrix metalloproteinaase 9 from U937 monocytic leukemia and HT1080 fibrosarcoma cells. Biochem J. 1992;285:603-611.
46. Heussen C, Dowdle EB. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem. 1980;102:196-202.
47. Lark MW, Walakovits LA, Shah TK, Vanmiddlesworth J, Cameron PM, Lin T. Production and purification of protostromelysin and procollagenase from 11-1 beta-stimulated human gingival fibroblasts. Connect Tissue Res, 1990;25:49-65.
48. Burnette WN. 'Western blotting': electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrytamide gels to unmodified nitrocellulose and radiographie detection with antibody and radioiodinated protein A. Anal Biochem. 1981;112:105-203.
49. Bjerrum OJ, Selmer JC, Lihme A. Native immunoblotting: transfer of membrane proteins in the presence of non-ionic detergent. Electrophoresis. 1987;8:388-397.
50. Okada T, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K, Hayakawa T. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. J Biol Chem. 1992; 267:21712-21719.
51. Atkinson SJ, Ward RV, Reynolds JJ, Murphy G. Cell-mediated degradation of type IV collagen and gelatin films is dependent on the activation of matrix metalloproteinases. Biochem J. 1992;288:605-611.
52. Werb Z, Hembry RM, Murphy G, Aggeler J. Commitment to expression of the metalloendopeptidases, collagenase and stromelysin: relationship of inducing events to changes in cytoskeletal architecture. J Cell Biol. 1986; 102:697-702.
53. Murphy G, Cockett MI, Stephens PE, Smith BJ, Docherty AJ. Stromelysin is an activator of procollagenase. Biochem J. 1987;248:265-268.
54. Rahko PS. Comparative efficacy of three indexes of left ventricular performance derived from pressure-volume loops in heart failure induced by tachypacing. J Am Coll Cardiol. 1994;23:209-218.
55. Moe GW, Angus C, Howard RJ, Parker TG, Armstrong PW. Evaluation of indices of left ventricular contractility and relaxation in evolving canine experimental heart failure. Cardiovasc Res. 1992;26:362-366.
56. Kiuchi K, Shannon KP, Komamura K, Cohen DJ, Bianchi C, Homey CJ, Vatner SF, Vatner DE. Myocardial β-adrenergic receptor function during the development of pacing induced heart failure. J Clin Invest. 1994;91;907-914.
57. Ping P, Lynch E, Hammond K. Increased myocardial β-adrenergic receptor kinase activity: an early abnormality in adrenergic signaling in heart failure. Circulation. 1994;90(suppl I):I-358. Abstract.
58. Calderone A, Bouvier M, Li K, Juneau C, De Champlain J, Rouleau JL. Dysfunction of the β- and α-adrenergic systems in a model of congestive heart failure. Circ Res. 1991;69:332-343.
59. 2+ cycle in congestive heart failure produced in dogs by idtopathic dilated cardiomypathy and rapid ventricular pacing. J Mol Cell Cardiol. 1994;26:173-184.
60. Perreault CL, Shannon RP, Komamura K, Vatner SF, Morgan JP. Abnormalities in intracellular calcium regulation and contractile function in myocardium from dogs with pacing induced heart failure. J Clin Invest. 1992;89:932-938.
61. Mukherjee D, Sen S. Collagen phenotypes during development and regression of myocardial hypertrophy in spontaneously hypertensive rats. Circ Res. 1990;67:1474-1480.
62. Takahashi S, Barry AC, Factor SM. Collagen degradation in ischemic rat hearts. Biochem J. 1990;265:233-241.
63. Cauwston TE, Curry VA, Clark IM, Hazleman BL. Identification of a new metalloproteinase inhibitor that forms tight binding complexes with collagenase. Biochem J. 1990;269:183-187.
64. Goldberg GI, Manner BL, Grant GA, Eisen AZ, Wilhelm S, Chengshi H. Human 72 kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc Natl Acad Sci U S A. 1989;86:8207-8211.
65. Scott BD, Sharma MK, Levett JM, Marinelli CC, Kieso RA, Schmid PG, Kerber RE. Cardiac geometry and mass changes associated with pacinginduced cardiomyopathy in the dog. Am Heart J. 1993;125:1047-1053.
66. Delhaas T, Arts T, Prinzen FW, Reneman RS. Relation between regional electrical activation time and subepicardial fiber strain in the canine left ventricle. Pflugers Arch. 1993;423:78-87.
67. Badke FR, Bionay P, Covell JW. Effects of ventricular pacing on regional left ventricular performance in the dog. Am J Physiol 1980;238: H858-H867.